Organization: Health Canada
Year: 2024
Month: August
Request Number: A-2023-001546
Request Summary: Medical Ingredient: "Ruxolitinib phosphate" Therapeutic Area: "Antineoplastic agents" Number of submissions under review: "1". The year and month in which the following submission was accepted for review; and the sponsor's name for the following submission.
Disposition: Disclosed in part
Number of pages: 1